Top Markets
#1 ADO Protocol ADO Protocol +194.49%
#2 Islamic Coin Islamic Coin +155.42%
#3 GoPlus Security GoPlus Security +40.36%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 TENDIES TENDIES +16.38%
#7 Verus Coin Verus Coin +13.64%
#8 Status Status +12.27%
#9 Tutorial Tutorial +11.58%
#10 Pons Pons +11.50%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Vascular Biogenics Ltd. Vascular Biogenics Ltd.

Vascular Biogenics Ltd.

VBLT
Classement en actions #33542
Vascular Biogenics Ltd. (VBLT) operates as a clinical-stage biopharmaceutical... Vascular Biogenics Ltd. (VBLT) operates as a clinical-stage biopharmaceutical company, dedicated to developing therapeutic solutions for cancer and immune-inflammatory diseases. The company's activities are concentrated in Israel and the United States. Its pipeline is anchored by two core technological platforms: First, a gene-based vascular targeting system that focuses on newly formed blood vessels; and second, an antibody-based monocyte targeting technology that aims to specifically inhibit monocyte migration, particularly for immune-inflammatory applications. VBLT's flagship product candidate, VB-111, a gene-based biologic, is undergoing several clinical trials. It has reached Phase III for the treatment of recurrent, platinum-resistant ovarian cancer. Additionally, it is in Phase II trials for recurrent glioblastoma and colorectal cancer. Moreover, VB-111 has completed Phase II clinical trials for thyroid cancer. The company is also developing VB-601 for a variety of inflammatory indications and VB-611 for different types of solid tumors. Initially incorporated as Medicard Ltd. in 2000, the company rebranded as Vascular Biogenics Ltd. in January 2003. Its main offices are situated in Modi'in, Israel.
Prix de l'action
$0.155
Dernière synchronisation: 2023-10-16
Capitalisation boursière
$7.44M
Changement (1 jour)
-9.36%
Changement (1 an)
0.00%
Pays
IL
Échange Vascular Biogenics Ltd. (VBLT)

Catégorie

Healthcare
Le prix VBLT avec la capitalisation boursière de B
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
$0.155
Capitalisation boursière de Vascular Biogenics Ltd.(VBLT)
Capitalisation boursière: $7.44M
En August 2026, Vascular Biogenics Ltd. a une capitalisation boursière de $7.44M. Cela fait de Vascular Biogenics Ltd. la 33542nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Vascular Biogenics Ltd. du 2014 au 2026
VBLT par rapport au top 5 des plus populaires stocks
Prix pour VBLT L’actif B La capitalisation boursière de B Résultats
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
$113,565 $7.44M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +73,267,592.46%
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
$93,529.19 $7.44M
Apple Inc. Apple Inc.
AAPL
$4.490T +60,341,315.64%
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
$86,704.86 $7.44M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +55,938,519.98%
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
$76,579.91 $7.44M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +49,406,294.36%
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
$59,013.59 $7.44M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +38,073,181.67%